Acylcarnitine values are shown in µM. *denotes a significant difference (P<0.05) from HF by post hoc Tukey test. Significantly different and trending (P<0.081) values from HF are bolded.
These were the metabonomics data from KPC mice which were divided into 8 groups and administered with the following regimens: PBS, mTOR inhibitor sirolimus, PD-L1 antibody, gemcitabine, sirolimus + PD
BackgroundVitamin A supplementation is an important public health intervention strategy to reduce childhood morbidity and mortality. However, in Ethiopia, the coverage remained low with significant re